Carlos Ramirez

Carlos practices corporate and securities law, with an emphasis on public company representation and capital markets transactions. He represents private and public companies in public offerings, private financings, mergers & acquisitions, corporate governance matters, and Securities and Exchange Commission reporting and compliance. He also advises venture capital and private equity funds and investment banking firms in connection with financings.

Carlos routinely represents issuers and investors in complex securities offerings, including initial public offerings, follow-on offerings, 144A offerings and private placements.

Carlos’ select recent transaction experience includes advising:

• Morphimmune on its merger with Immunome and $125 million private placement
• ViaCyte on its sale to Vertex Pharmaceuticals for $320 million
• Uber on its sale of 50% stake in Careem’s super app business unit to e&
• The Honest Company on its $474.8 million IPO
• Uber on its offerings of $1.5 billion 4.5% senior notes due 2029 and $1.15 billion 0% convertible senior notes due 2025
• ASLAN Pharmaceuticals on several equity offerings with an aggregate value of $125.7 million
• MannKind on its offering of $230 million aggregate principal amount 2.5% convertible senior notes due 2026 and $40 million follow-on offering
• Metacrine on its $85 million IPO
• Vir Biotechnology on its $142.9 million IPO and $345 million follow-on offering
• Acadia Pharmaceuticals on several equity offerings with an aggregate value of $525 million
• Allogene Therapeutics on its $324 million IPO and $632.5 million follow-on offering
• Alarm.com on its $266.8 million follow-on offering
• The underwriters on several follow-on offerings for Ascendis Pharma with an aggregate value of $1.2 billion
• The initial purchasers on Zendesk’s offering of $1.15 billion aggregate principal amount 0.625% convertible senior notes due 2025
• Drata on its $100 million Series B financing

Carlos serves as a member of Cooley’s diversity committee, and he is actively engaged in the firm’s diversity, equity and inclusion initiatives. In 2020, he was honored with a Top Lawyers Under 40 Award from the Hispanic National Bar Association.

Carlos is a member of the board of directors of San Diego Squared (SD2), a STEM-focused nonprofit established in 2020 to connect underrepresented students to the power of science, technology, engineering and math by providing access to education, mentorship, and the resources students need to lead the talent pipeline.

Before attending law school, Carlos was a senior associate in the audit practice for Deloitte, where he served private and public companies in conducting audits and reviews of financial statements and internal controls. He is a former certified public accountant (CPA) in the state of California (license inactive).